share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  11/19 05:32

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction, dated 11/15/2024, did not specify the number of shares involved or the transaction price. The nature of the shares and the total value of the transaction were also not disclosed. As of the latest filing, the details regarding the number of shares held by Bourla after the action remain undisclosed.
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction, dated 11/15/2024, did not specify the number of shares involved or the transaction price. The nature of the shares and the total value of the transaction were also not disclosed. As of the latest filing, the details regarding the number of shares held by Bourla after the action remain undisclosed.
輝瑞公司(PFE)報告了一項涉及其董事長兼首席執行官阿爾伯特·布爾拉的交易。該交易的日期爲2024年11月15日,但未說明涉及的股票數量或交易價格。股票的性質和交易的總值也未披露。根據最新的備案,布爾拉在該行動後的股票持有數量仍未披露。
輝瑞公司(PFE)報告了一項涉及其董事長兼首席執行官阿爾伯特·布爾拉的交易。該交易的日期爲2024年11月15日,但未說明涉及的股票數量或交易價格。股票的性質和交易的總值也未披露。根據最新的備案,布爾拉在該行動後的股票持有數量仍未披露。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。